The Life Sciences Tools and Services industry on FinBizNet covers 27 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 27 |
|---|---|
| Combined market cap | ₹5,41,141 Cr |
| Median P/E (profitable companies) | 45.0 |
| Median return on equity | 8.1% |
| Companies with latest quarterly results | 22 of 27 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Divis Laboratories Limited | ₹3,01,758 Cr | 118.4 | 16.2% | ₹3,676 Cr | ₹1,127 Cr | Q2 FY27 |
| Anthem Biosciences Limited | ₹53,926 Cr | 90.1 | 19.4% | ₹594 Cr | ₹211 Cr | Q2 FY27 |
| Sai Life Sciences Limited | ₹40,755 Cr | 116.1 | 15.1% | ₹659 Cr | ₹98 Cr | Q2 FY27 |
| Onesource Specialty Pharma Limited | ₹18,138 Cr | — | -1.3% | ₹516 Cr | ₹57 Cr | Q2 FY27 |
| Cohance Lifesciences Ltd | ₹17,756 Cr | 100.6 | 5.1% | ₹477 Cr | ₹2 Cr | Q2 FY27 |
| Syngene International Ltd. | ₹17,630 Cr | 56.9 | 6.6% | ₹833 Cr | ₹32 Cr | Q2 FY27 |
| Jubilant Pharmova Ltd | ₹15,556 Cr | 39.1 | 6.0% | ₹2,370 Cr | ₹31 Cr | Q2 FY27 |
| Indegene Ltd | ₹14,840 Cr | 40.2 | 13.9% | ₹1,122 Cr | ₹112 Cr | Q2 FY27 |
| Concord Biotech Ltd | ₹12,495 Cr | 24.2 | 13.5% | ₹309 Cr | ₹70 Cr | Q2 FY27 |
| Akums Drugs and Pharmaceuticals Limited | ₹11,787 Cr | 45.0 | 8.0% | ₹1,342 Cr | ₹115 Cr | Q2 FY27 |
| Blue Jet Healthcare Ltd | ₹10,140 Cr | 38.0 | 19.9% | ₹376 Cr | ₹103 Cr | Q2 FY27 |
| Suven Life Sciences Ltd. | ₹7,951 Cr | — | -78.8% | ₹1 Cr | ₹-107 Cr | Q2 FY27 |
| INNOVA CAPTAB LIMITED | ₹6,249 Cr | 47.3 | 14.0% | ₹496 Cr | ₹42 Cr | Q2 FY27 |
| Dishman Carbogen Amcis Ltd | ₹2,744 Cr | 28.0 | 1.6% | ₹507 Cr | ₹-67 Cr | Q2 FY27 |
| Vimta Labs Ltd | ₹2,259 Cr | 29.5 | 18.6% | ₹112 Cr | ₹21 Cr | Q2 FY27 |
| Windlas Biotech Ltd | ₹2,060 Cr | 32.6 | 12.2% | ₹264 Cr | ₹18 Cr | Q2 FY27 |
| Tarsons Products Limited | ₹1,730 Cr | 114.9 | 2.3% | ₹124 Cr | ₹-0 Cr | Q2 FY27 |
| Borosil Scientific Limited | ₹992 Cr | 28.7 | 8.2% | ₹115 Cr | ₹5 Cr | Q2 FY27 |
| Fabtech Technologies Limited | ₹620 Cr | 14.2 | 9.1% | ₹92 Cr | ₹15 Cr | Q2 FY27 |
| Influx Healthtech Limited | ₹588 Cr | 28.7 | 20.4% | — | — | — |
| Rays of Belief Limited | ₹536 Cr | 90.6 | — | ₹27 Cr | ₹3 Cr | Q2 FY27 |
| Brooks Laboratories Ltd. | ₹198 Cr | 7.9 | 22.3% | ₹19 Cr | ₹68 Cr | Q2 FY27 |
| Bilcare Ltd. | ₹194 Cr | 108.3 | -5.2% | — | — | — |
| Jeevan Scientific Technology Ltd | ₹176 Cr | 129.4 | 1.7% | — | — | — |
| Vivo Bio Tech Ltd. | ₹37 Cr | — | -2.0% | ₹14 Cr | ₹0 Cr | Q1 FY27 |
| Dr. Habeebbullal Life Sciences Ltd | ₹26 Cr | — | -68.8% | — | — | — |
| Vanta Bioscience Ltd | ₹0 Cr | 132.3 | 0.9% | — | — | — |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 27 listed companies in the Life Sciences Tools and Services industry, including Divis Laboratories Limited, Anthem Biosciences Limited, Sai Life Sciences Limited, Onesource Specialty Pharma Limited, Cohance Lifesciences Ltd, Syngene International Ltd., Jubilant Pharmova Ltd, Indegene Ltd, among others.
By market capitalisation, the largest Life Sciences Tools and Services companies are Divis Laboratories Limited (₹3,01,758 Cr), Anthem Biosciences Limited (₹53,926 Cr), Sai Life Sciences Limited (₹40,755 Cr), Onesource Specialty Pharma Limited (₹18,138 Cr), Cohance Lifesciences Ltd (₹17,756 Cr).
The 27 Life Sciences Tools and Services companies tracked on FinBizNet have a combined market capitalisation of about ₹5,41,141 Cr.
The median price-to-earnings ratio across 23 profitable Life Sciences Tools and Services companies is 45.0, and the median return on equity across the industry is 8.1%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Life Sciences Tools and Services industry.